News | 11.23.20
Vasospasm Indication Approved in Europe for Rapid Medical’s Comaneci Device
November 23, 2020—Rapid Medical, an Israel-based company focused on the development of next-generation neurovascular devices, announced CE Mark approval for the expanded indication of the Comaneci adjustable remodeling mesh device to treat cerebral vasospasm.
News | 11.19.20
SVIN Task Force Evaluates Paradigm Shifts in Medical Care During COVID-19 Pandemic
November 19, 2020—The Society of Vascular and Interventional Neurology (SVIN) announced the release of a study by James Siegler, MD, and SVIN investigators that identifies the significant changes in medical care caused by the COVID-19 pandemic, from triage to treatment.
News | 11.12.20
Avicenna.AI Provides Cina Head AI Triage Solution for Canon’s Automation Platform
November 12, 2020—Avicenna.AI, a medical imaging artificial intelligence (AI) specialist based in La Ciotat, France, announced a partnership with Canon Medical Systems Corporation to deliver a fully integrated stroke detection AI solution for Canon’s automation platform.
News | 11.10.20
Penumbra Partners With RapidAI on Pulmonary Embolism Triage and Decision-Making
November 10, 2020—Penumbra, Inc. has announced a partnership with artificial intelligence company RapidAI aimed at enabling faster clinical decision-making for pulmonary embolism (PE) diagnosis and procedures. Penumbra says the companies will work together to develop clinical and communications modules for PE with a goal of streamlining triage and decision-making by processing CT scans and delivering them to physicians.
News | 11.06.20
AstraZeneca’s Brilinta Is Approved to Reduce the Risk of Stroke
November 6, 2020—AstraZeneca announced that Brilinta (ticagrelor) has been approved in the United States to reduce the risk of stroke in patients with acute ischemic stroke (National Institutes of Health Stroke Scale score ≤ 5) or high-risk transient ischemic attack (TIA).
News | 10.29.20
SVIN’s Mission Thrombectomy 2020+ Global Campaign Issues White Paper on Improving Awareness, Accessibility, and Action
October 29, 2020—The Society of Vascular and Interventional Neurology (SVIN) announced that is global campaign, Mission Thrombectomy 2020+ (MT2020+), has issued a white paper, “Mechanical Thrombectomy for Acute Stroke.
News | 10.29.20
Bendit Technologies Reports Successful FIH Use of Its Steerable Neuro Microcatheter
October 29, 2020—Bendit Technologies, an Israel-based medical device company, announced the successful results of the first-in-human use of the Bendit steerable neuro microcatheter at Sheba Medical Center in Tel Aviv, Israel.
News | 10.15.20
FDA Clears See-Mode Technologies’ Augmented Vascular Analysis AI Software
October 15, 2020—See-Mode Technologies announced that it has received FDA 510(k) clearance for its debut product, Augmented Vascular Analysis (AVA), a medical artificial intelligence software for automated analysis and reporting of vascular ultrasound scans for stroke prediction.
News | 10.14.20
GNT Pharma Reports Results From Phase 2 SONIC Study of Nelonemdaz for Acute Ischemic Stroke Patients Treated With Endovascular Thrombectomy
October 14, 2020—GNT Pharma Inc., a South Korea–based developer of drug and technology for the treatment of patients with neurological and inflammatory diseases, reported top-line results from the phase 2 SONIC study assessing the safety and efficacy of nelonemdaz in acute ischemic stroke patients treated with endovascular thrombectomy within 8 hours of symptom onset.
News | 09.24.20
Philips Announces FDA 510(k) Clearance and Launch of QuickClear Mechanical Thrombectomy System
September 24, 2020—Royal Philips announced the FDA 510(k) clearance and launch of their QuickClear mechanical thrombectomy system, a compact, single-use system that provides physicians an all-in-one aspiration pump and catheter for the removal of blood clots from the vessels of the peripheral arterial and venous systems.
News | 09.16.20
Vesalio Expands International Distribution of NeVa Thrombectomy System
September 16, 2020—Vesalio LLC announced it has executed additional exclusive distribution agreements in Europe, Latin America, Asia, and the Middle East that expand market coverage in 53 countries for the company’s NeVa neurovascular thrombectomy system for first-pass recanalization in acute ischemic stroke.
News | 09.09.20
News | 08.07.20
US Device Guide
This Device Guides offers a searchable, comprehensive listing of the available vascular interventional devices in the United States.
European Device Guide
This Device Guides offers a searchable, comprehensive listing of the available vascular interventional devices in Europe.